SKBA Capital Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.9M | Hold |
70,693
| – | – | 2.87% | 9 |
|
|
2025
Q4 | $19.3M | Sell |
70,693
-20
| -0% | -$5.43K | 2.74% | 3 |
|
|
2025
Q3 | $19.1M | Buy |
70,713
+750
| +1% | +$204K | 2.64% | 7 |
|
|
2025
Q2 | $19.3M | Sell |
69,963
-5,270
| -7% | -$1.43M | 2.77% | 7 |
|
|
2025
Q1 | $20M | Buy |
75,233
+1,543
| +2% | +$381K | 2.97% | 6 |
|
|
2024
Q4 | $17.1M | Buy |
73,690
+1,280
| +2% | +$294K | 2.7% | 6 |
|
|
2024
Q3 | $16M | Sell |
72,410
-50
| -0.1% | -$10.3K | 2.37% | 12 |
|
|
2024
Q2 | $14.2M | Sell |
72,460
-350
| -0.5% | -$72.3K | 2.29% | 14 |
|
|
2024
Q1 | $15.7M | Sell |
72,810
-200
| -0.3% | -$42K | 2.45% | 11 |
|
|
2023
Q4 | $15.4M | Buy |
73,010
+220
| +0.3% | +$46.9K | 2.59% | 10 |
|
|
2023
Q3 | $14.6M | Buy |
72,790
+990
| +1% | +$197K | 2.69% | 8 |
|
|
2023
Q2 | $13.3M | Buy |
71,800
+26,810
| +60% | +$4.95M | 2.4% | 11 |
|
|
2023
Q1 | $8.62M | Buy |
44,990
+1,050
| +2% | +$190K | 1.61% | 32 |
|
|
2022
Q4 | $7.39M | Buy |
43,940
+8,030
| +22% | +$1.4M | 1.37% | 39 |
|
|
2022
Q3 | $6.36M | Buy |
35,910
+400
| +1% | +$79.1K | 1.35% | 39 |
|
|
2022
Q2 | $7.27M | Buy |
35,510
+100
| +0.3% | +$21.2K | 1.45% | 39 |
|
|
2022
Q1 | $8.42M | Sell |
35,410
-1,000
| -3% | -$235K | 1.52% | 34 |
|
|
2021
Q4 | $8.32M | Buy |
36,410
+610
| +2% | +$134K | 1.57% | 31 |
|
|
2021
Q3 | $6.92M | Buy |
35,800
+12,300
| +52% | +$2.49M | 1.38% | 35 |
|
|
2021
Q2 | $5M | Sell |
23,500
-7,400
| -24% | -$1.56M | 0.98% | 50 |
|
|
2021
Q1 | $6.31M | Sell |
30,900
-1,500
| -5% | -$295K | 1% | 48 |
|
|
2020
Q4 | $5.9M | Buy |
+32,400
| New | +$5.51M | 0.99% | 50 |
|
|
2016
Q2 | – | Sell |
-2,700
| Closed | -$259K | – | 82 |
|
|
2016
Q1 | $259K | Sell |
2,700
-100
| -4% | -$9.1K | 0.03% | 77 |
|
|
2015
Q4 | $254K | Sell |
2,800
-400
| -13% | -$37.6K | 0.03% | 80 |
|
|
2015
Q3 | $297K | Sell |
3,200
-52,300
| -94% | -$4.97M | 0.03% | 80 |
|
|
2015
Q2 | $5.17M | Sell |
55,500
-49,900
| -47% | -$4.66M | 0.4% | 63 |
|
|
2015
Q1 | $9.98M | Sell |
105,400
-15,900
| -13% | -$1.47M | 0.78% | 47 |
|
|
2014
Q4 | $10.8M | Sell |
121,300
-12,300
| -9% | -$1.04M | 0.83% | 44 |
|
|
2014
Q3 | $10.7M | Sell |
133,600
-46,600
| -26% | -$3.51M | 0.89% | 44 |
|
|
2014
Q2 | $12.8M | Sell |
180,200
-15,230
| -8% | -$1.07M | 1.13% | 38 |
|
|
2014
Q1 | $14.5M | Buy |
195,430
+39,800
| +26% | +$3M | 1.35% | 36 |
|
|
2013
Q4 | $12.2M | Sell |
155,630
-3,400
| -2% | -$266K | 1.43% | 34 |
|
|
2013
Q3 | $11.7M | Sell |
159,030
-84,400
| -35% | -$6.22M | 1.42% | 38 |
|
|
2013
Q2 | $18.5M | Buy |
+243,430
| New | +$16M | 2.18% | 14 |
|
Other funds holding CME
VCM
VPM
SKBA Capital Management's CME Position: Q1 2026 in Review
SKBA Capital Management held its CME Group (CME) position steady in Q1 2026 at 70,693 shares worth $20.9M. The position accounts for 2.87% of the portfolio, ranked #9.
SKBA Capital Management first reported a position in CME in Q2 2013 and has held it in 34 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- SKBA Capital Management held 70,693 shares of CME Group worth $20.9M as of Q1 2026.
- SKBA Capital Management left its CME Group share count unchanged in Q1 2026.
- CME Group made up 2.87% of SKBA Capital Management's portfolio in Q1 2026, its #9 holding.
- SKBA Capital Management first reported a position in CME Group in Q2 2013 and has held it in 34 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on SKBA Capital Management's 13F filing for Q1 2026, filed 13 May 2026.